Clinical Trial Update: Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Exercise Treadmill Test indices in participants with cardiovascular disease has terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• Novartis Pharmaceuticals

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atherosclerotic Coronary Vascular Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-06-18